The first true pharmaceutical distribution venture in South Africa, International Health Care (Pty) Ltd, is claiming success after its first nine months of operation.
The jointly-owned, non-profit, cooperative organization was formed in December last year by the multinatio nal drug companies Bayer, Boehringer Ingelheim, Ciba and Roche (which has subsequently also acquired part of the Fisons business) to serve as the sole agent for the principal manufacturers' ranges of approximately 500 products. Other manufacturers distribute through wholesalers.
With the sizeable gray activities market in South Africa (see also Marketletter October 24), estimated at 750 million rand ($213.8 million) per annum, one of IHC's main objectives was to create an effective distribution system in order to control the destiny of products from manufacturer to dispenser or prescriber, the company's marketing executive Nick Brummer explained. This would ensure the safety, efficacy and stability of products.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze